{"mainPropery":{"diseaseId":7629,"diseaseName":"Sezary syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7629/sezary-syndrome","synonyms":["Sezary's lymphoma","Sézary syndrome"],"synonyms-with-source":[{"name":"Sezary's lymphoma"},{"name":"Sézary syndrome"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"3162"},{"identifierType":"UMLS","identifierId":"C0036920"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":462,"resourceName":"Cutaneous Lymphoma Foundation","abbreviation":"","address1":"PO Box 374","address2":"","address3":"","address4":"","address5":"","city":"Birmingham","state":"MI","zip":"48012","country":"United States","phone":"+1-248-644-9014","tty":"","tollFree":"","fax":"+1-248-644-9014","email":"info@clfoundation.org","url":"https://www.clfoundation.org/","freeText":"Facebook: https://www.facebook.com/clfoundation"},{"resourceID":570,"resourceName":"Leukemia and Lymphoma Society","abbreviation":"","address1":"3 International Drive, Suite 200","address2":"","address3":"","address4":"","address5":"","city":"Rye Brook","state":"NY","zip":"10573","country":"United States","phone":"1-(888) 557-7177 (general)","tty":"","tollFree":"1-(800) 955-4572 (patients and families)","fax":"","email":"https://www.lls.org/content/contact-us","url":"https://www.lls.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Sezary%20Syndrome%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Sezary syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Sezary+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Sezary syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/sezary-syndrome' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Sezary syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1124/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/204529-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3162' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=3400&Disease(s)%20concerned=Classical-mycosis-fungoides&search=ResearchTrials_ResearchProjects_Simple&ChdId=3400&ResearchTrials_ResearchTrials_ResearchProjects_diseaseGroup=mycosis-fung&ResearchTrials_ResearchTrials_ResearchProjects_diseaseType=Pat&ResearchTrials_ResearchTrials_ResearchProjects_country=NN&ResearchTrials_ResearchTrials_ResearchProjects_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/mycosisfungoides/Patient' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/dermal-infiltrative/cutaneous-t-cell-lymphoma.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:8541' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/cutaneous-t-cell-lymphoma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":2650,"questionText":"What is Sezary syndrome?","answerText":"<strong>Sezary syndrome</strong> is an aggressive form of <a href=\"https://rarediseases.info.nih.gov/gard/6226/cutaneous-t-cell-lymphoma/resources/1\" target=\"_blank\">cutaneous T-cell lymphoma</a> which is a group of disorders that occur when <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003516.htm\" target=\"_blank\">T-cells</a> (a type of white blood cell) become cancerous and affect the skin. It is characterized by a widespread red rash that may cover most of the body, the presence of cancerous T cells (called Sezary cells) in the blood, and abnormally enlarged lymph nodes. Other signs and symptoms may include intense itchiness, scaling and peeling of the skin; fever; weight loss; hair loss; outward turning of the eyelids (ectropion); <a href=\"http://dermnetnz.org/scaly/palmoplantar-keratoderma.html\" target=\"_blank\">palmoplantar keratoderma</a>; malformation of the nails; and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=\"_blank\">hepatosplenomegaly</a>. The exact cause of Sezary syndrome is currently unknown. Treatment varies based on the signs and symptoms present in each person and the severity of the condition.[9413][9416]","dateModified":"2015-08-03T00:00:00"},"basicQuestions":[{"questionId":9199,"questionText":"What are the signs and symptoms of Sezary syndrome?","answerText":"Sezary syndrome is an aggressive form of <a href=\"https://rarediseases.info.nih.gov/gard/6226/cutaneous-t-cell-lymphoma/resources/1\" target=\"_blank\">cutaneous T-cell lymphoma</a> which is a group of disorders that occur when <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003516.htm\" target=\"_blank\">T-cells</a> (a type of white blood cell) become cancerous and affect the skin. In Sezary syndrome, specifically, the cancerous T cells are called Sezary cells and are found in the skin, lymph nodes, and blood. They can also spread to other organs in the body, including the liver, spleen, and bone marrow.[9413][9414]<br />\r\n<br />\r\nAlthough Sezary syndrome can affect people of all ages, it is most commonly diagnosed in adults over age 60. The signs and symptoms of this condition can vary but may include:[9413][9414]\r\n<ul>\r\n    <li>A red, itchy rash that covers large portions of the body</li>\r\n    <li>Enlarged lymph nodes</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/hairloss.html\" target=\"_blank\">Alopecia</a> (hair loss)</li>\r\n    <li>Thickened skin on the palms of the hands and soles of the feet</li>\r\n    <li>Abnormalities of the fingernails and toenails</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001007.htm\" target=\"_blank\">Ectropion</a></li>\r\n    <li>Hepatosplenomegaly (enlarged liver and spleen)</li>\r\n</ul>\r\n<br />\r\nAffected people may also have an increased risk of developing another <a href=\"http://www.nlm.nih.gov/medlineplus/lymphoma.html\" target=\"_blank\">lymphoma</a> or other type of cancer.[9414]","dateModified":"2015-07-30T15:15:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9413,"authors":"Lauren C Pinter-Brown, MD","articleTitle":"Cutaneous T-Cell Lymphoma","bookWebsiteJournalTitle":"Medscape Reference","date":"March 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2139720-overview#showall","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9414,"authors":"Elise A Olsen, MD; Alain H Rook, MD","articleTitle":"UpToDate","bookWebsiteJournalTitle":"Clinical presentation, pathologic features, and diagnosis of Sézary syndrome","date":"May 2013","volume":"","pages":"","url":"","dateAccessed":"2015-07-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6168,"questionText":"What causes Sezary syndrome?","answerText":"Although a small percentage of cases of Sezary syndrome are associated with human T-lymphotropic viruses <a href=\"https://rarediseases.info.nih.gov/gard/9645/human-t-cell-leukemia-virus-type-1/resources/1\" target=\"_blank\">type 1</a> and <a href=\"https://rarediseases.info.nih.gov/gard/9783/human-t-cell-leukemia-virus-type-2/resources/1\" target=\"_blank\">type 2</a>, the underlying cause of most cases is currently unknown.[9414] In people affected by the condition, the cancerous T-cells (also called Sezary cells) usually have one or more <a href=\"http://www.genome.gov/11508982#al-5\" target=\"_blank\">chromosomal abnormalities</a>. These genetic changes are considered \"<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic</a>\" because they are acquired during a person's lifetime, are not inherited and only affect the <a href=\"https://www.genome.gov/25520880\" target=\"_blank\">DNA</a> of the cancerous cells. Although any chromosome can be affected, people with Sezary syndrome often have <a href=\"https://www.genome.gov/glossary/index.cfm?id=45\" target=\"_blank\">deletions</a> of DNA from chromosomes 10 and 17 or <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/duplication/\" target=\"_blank\">duplications</a>  of DNA on chromosomes 8 and 17. However, it is unclear whether these alterations play a role in the development of the condition.[9415]","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":9414,"authors":"Elise A Olsen, MD; Alain H Rook, MD","articleTitle":"UpToDate","bookWebsiteJournalTitle":"Clinical presentation, pathologic features, and diagnosis of Sézary syndrome","date":"May 2013","volume":"","pages":"","url":"","dateAccessed":"2015-07-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9415,"authors":"","articleTitle":"Sézary syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sezary-syndrome","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6167,"questionText":"Is Sezary syndrome inherited?","answerText":"The underlying cause of Sezary syndrome is unknown in most cases. However, it generally occurs <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadically</a> in people with no family history of the condition.[9415]","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":9415,"authors":"","articleTitle":"Sézary syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sezary-syndrome","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9200,"questionText":"How is Sezary syndrome diagnosed?","answerText":"A diagnosis of Sezary syndrome is often suspected in people with characteristic <a href=\"https://rarediseases.info.nih.gov/gard/7629/sezary-syndrome/resources/9\" target=\"_blank\">signs and symptoms</a>. Additional testing can then be ordered to confirm the diagnosis. This may include:[9416][9414]\r\n<ul>\r\n    <li>A skin biopsy</li>\r\n    <li>A complete blood count</li>\r\n    <li>Peripheral blood smear</li>\r\n    <li>Immunophenotyping</li>\r\n    <li>T-cell receptor (TCR) gene rearrangement test</li>\r\n    <li>Flow cytometry</li>\r\n</ul>\r\n<br />\r\nTo learn more about the diagnosis of Sezary syndrome, including specific information about each of the tests listed above, please visit the <a href=\"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq\" target=\"_blank\">National Cancer Institute's</a> Web site. Simply click on the link and scroll down to the section entitled \"tests that examine the skin and blood are used to detect (find) and diagnose mycosis fungoides and the Sezary syndrome\"","dateModified":"2015-07-30T21:43:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9414,"authors":"Elise A Olsen, MD; Alain H Rook, MD","articleTitle":"UpToDate","bookWebsiteJournalTitle":"Clinical presentation, pathologic features, and diagnosis of Sézary syndrome","date":"May 2013","volume":"","pages":"","url":"","dateAccessed":"2015-07-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9416,"authors":"","articleTitle":"Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)","bookWebsiteJournalTitle":"National Cancer Institute","date":"May 2015","volume":"","pages":"","url":"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4058,"questionText":"How might Sezary syndrome be treated?","answerText":"In general, there are six different treatment options available to people with Sezary syndrome. These include:[9416]\r\n<ul>\r\n    <li>Photodynamic therapy</li>\r\n    <li>Radiation therapy</li>\r\n    <li>Chemotherapy </li>\r\n    <li>Other drug therapy (i.e. topical steriods, retinoids)</li>\r\n    <li>Biologic therapy</li>\r\n    <li>Targeted therapy</li>\r\n</ul>\r\n<br />\r\nTo learn more about the treatment and management of Sezary syndrome, including specific information about each of the treatments listed above, please visit the <a href=\"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq#section/_50\" target=\"_blank\">National Cancer Institute's</a> Web site. Simply click on the link to access this resource.","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9416,"authors":"","articleTitle":"Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)","bookWebsiteJournalTitle":"National Cancer Institute","date":"May 2015","volume":"","pages":"","url":"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9211,"questionText":"What is the long-term outlook for people with Sezary syndrome?","answerText":"The long-term outlook (prognosis) for people with Sezary syndrome is generally poor. Sezary syndrome is difficult to cure. Treatment is usually <a href=\"http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45815&amp;version=Patient&amp;language=English\" class=\"Summary-GlossaryTermRef\" target=\"_blank\">palliative</a>, with the intention of relief of symptoms and improvement in the <a href=\"http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45417&amp;version=Patient&amp;language=English\" class=\"Summary-GlossaryTermRef\" target=\"_blank\">quality of life</a>. Median survival for patients with Sezary syndrome has been reported to be 2 to 4 years after development of the condition, although survival has improved with newer treatments. The disease-specific 5-year survival rate has been reported to be 24%.[9416][9415]","dateModified":"2015-08-03T15:01:00","resourceClassificationName":"Prognosis","references":[{"referenceId":9415,"authors":"","articleTitle":"Sézary syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sezary-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9416,"authors":"","articleTitle":"Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)","bookWebsiteJournalTitle":"National Cancer Institute","date":"May 2015","volume":"","pages":"","url":"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6226,"relatedDiseaseName":"Cutaneous T-cell lymphoma","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":34960,"abbreviatedInquiry":"Is Sezary syndrome hereditary? My father had this and now I think my sister has it.","caseQuestions":[{"questionId":6167,"questionText":"Is Sezary syndrome inherited?","answerText":"The underlying cause of Sezary syndrome is unknown in most cases. However, it generally occurs <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/sporadic/\" target=\"_blank\">sporadically</a> in people with no family history of the condition.[9415]","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":9415,"authors":"","articleTitle":"Sézary syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sezary-syndrome","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6168,"questionText":"What causes Sezary syndrome?","answerText":"Although a small percentage of cases of Sezary syndrome are associated with human T-lymphotropic viruses <a href=\"https://rarediseases.info.nih.gov/gard/9645/human-t-cell-leukemia-virus-type-1/resources/1\" target=\"_blank\">type 1</a> and <a href=\"https://rarediseases.info.nih.gov/gard/9783/human-t-cell-leukemia-virus-type-2/resources/1\" target=\"_blank\">type 2</a>, the underlying cause of most cases is currently unknown.[9414] In people affected by the condition, the cancerous T-cells (also called Sezary cells) usually have one or more <a href=\"http://www.genome.gov/11508982#al-5\" target=\"_blank\">chromosomal abnormalities</a>. These genetic changes are considered \"<a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46586\" target=\"_blank\">somatic</a>\" because they are acquired during a person's lifetime, are not inherited and only affect the <a href=\"https://www.genome.gov/25520880\" target=\"_blank\">DNA</a> of the cancerous cells. Although any chromosome can be affected, people with Sezary syndrome often have <a href=\"https://www.genome.gov/glossary/index.cfm?id=45\" target=\"_blank\">deletions</a> of DNA from chromosomes 10 and 17 or <a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/duplication/\" target=\"_blank\">duplications</a>  of DNA on chromosomes 8 and 17. However, it is unclear whether these alterations play a role in the development of the condition.[9415]","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":9414,"authors":"Elise A Olsen, MD; Alain H Rook, MD","articleTitle":"UpToDate","bookWebsiteJournalTitle":"Clinical presentation, pathologic features, and diagnosis of Sézary syndrome","date":"May 2013","volume":"","pages":"","url":"","dateAccessed":"2015-07-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9415,"authors":"","articleTitle":"Sézary syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sezary-syndrome","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":29398,"abbreviatedInquiry":"Can Sezary syndrome be cured?","caseQuestions":[{"questionId":4057,"questionText":"Can Sezary syndrome be cured?","answerText":"Sezary syndrome is difficult to cure. Treatment is usually <a href=\"http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45815&amp;version=Patient&amp;language=English\" class=\"Summary-GlossaryTermRef\" target=\"_blank\">palliative</a>, with the intention of relief of symptoms and improvement in the <a href=\"http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=45417&amp;version=Patient&amp;language=English\" class=\"Summary-GlossaryTermRef\" target=\"_blank\">quality of life</a>. Patients may live many years with the disease.[9416]","dateModified":"2015-08-03T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9416,"authors":"","articleTitle":"Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)","bookWebsiteJournalTitle":"National Cancer Institute","date":"May 2015","volume":"","pages":"","url":"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4058,"questionText":"How might Sezary syndrome be treated?","answerText":"In general, there are six different treatment options available to people with Sezary syndrome. These include:[9416]\r\n<ul>\r\n    <li>Photodynamic therapy</li>\r\n    <li>Radiation therapy</li>\r\n    <li>Chemotherapy </li>\r\n    <li>Other drug therapy (i.e. topical steriods, retinoids)</li>\r\n    <li>Biologic therapy</li>\r\n    <li>Targeted therapy</li>\r\n</ul>\r\n<br />\r\nTo learn more about the treatment and management of Sezary syndrome, including specific information about each of the treatments listed above, please visit the <a href=\"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq#section/_50\" target=\"_blank\">National Cancer Institute's</a> Web site. Simply click on the link to access this resource.","dateModified":"2015-07-30T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9416,"authors":"","articleTitle":"Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)","bookWebsiteJournalTitle":"National Cancer Institute","date":"May 2015","volume":"","pages":"","url":"http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4059,"questionText":"How can I learn about research opportunities for individuals with Sezary syndrome?","answerText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"https://clinicaltrials.gov/ct2/results?term=Sezary+syndrome&amp;Search=Search\" target=\"_blank\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. Currently,&nbsp;there are several&nbsp;clinical trials are identified as enrolling individuals with Sezary syndrome. To find these trials, click on the link above. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check this site often for regular updates.<br />\r\n<br />\r\nYou can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling 1-800-411-1222 to speak with a specialist, who can help you determine if you are eligible for any clinical trials. If you are located outside the United States, and would like to be contacted via telephone, you will need to contact PRPL and provide your telephone number in full, including area code and international dialing prefix.<br />\r\n<br />\r\nPatient Recruitment and Public Liaison Office<br />\r\nNIH Clinical Center<br />\r\nBethesda, Maryland 20892-2655<br />\r\nToll-free: 1-800-411-1222<br />\r\nFax: 301-480-9793<br />\r\nE-mail: <a href=\"mailto:prpl@mail.cc.nih.gov\" target=\"_blank\">prpl@mail.cc.nih.gov</a><br />\r\nWeb site:  <a href=\"http://clinicalcenter.nih.gov/\" target=\"_blank\">http://clinicalcenter.nih.gov</a><br />\r\n<br />\r\nYou can find information about participating in a clinical trial as well as learn about resources for travel and lodging assistance, through the <a href=\"https://rarediseases.info.nih.gov/research/10/get-involved-in-research\" target=\"_blank\">Get Involved in Research</a> section of our Web site.","dateModified":"2015-08-03T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3615,"phenoTypeName":"Abnormal lymphocyte morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4894,"phenoTypeName":"Cutaneous T-cell lymphoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10279,"phenoTypeName":"Dry skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8301,"phenoTypeName":"Erythroderma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11809,"phenoTypeName":"Lichenification","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14467,"phenoTypeName":"Neoplasm of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8271,"phenoTypeName":"Pruritus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4756,"phenoTypeName":"Alopecia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10673,"phenoTypeName":"Immunodeficiency","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13345,"phenoTypeName":"Nail dystrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8267,"phenoTypeName":"Palmoplantar keratoderma","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13100,"phenoTypeName":"Abnormal facial shape","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4820,"phenoTypeName":"Abnormal immunoglobulin level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13735,"phenoTypeName":"Abnormal pleura morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10132,"phenoTypeName":"Ectropion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8259,"phenoTypeName":"Edema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1833,"phenoTypeName":"Gangrene","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5161,"phenoTypeName":"Irregular hyperpigmentation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":731,"genericName":"Mogamulizumab","tradeName":"Poteligeo","tradeLink":"http://poteligeo.com/","manufacturer":"","sponsor":"Kyowa Kirin Pharmaceutical Development Inc.","indication":"August 2018, mogamulizumab (Poteligeo) was approved for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/poteligeo","medlinePlusLink":""}],"EncodedName":"Sezary_syndrome"}